Small Volume Nefopam Hydrochloride Injection

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: Injection
Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP
  • Small Volume Nefopam Hydrochloride Injection
  • Small Volume Nefopam Hydrochloride Injection
  • Small Volume Nefopam Hydrochloride Injection
  • Small Volume Nefopam Hydrochloride Injection
  • Small Volume Nefopam Hydrochloride Injection
  • Small Volume Nefopam Hydrochloride Injection
Find Similar Products

Basic Info.

Model NO.
Small Volume Injection
Suitable for
Elderly, Adult
State
Liquid
Shape
Injection
Type
Inorganic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
H13020028
Packaging Design
Yes
Transport Package
Glass Ampoule
Specification
2ml
Trademark
SHIMEN
Origin
Heibi
HS Code
3004909099
Production Capacity
1000000000 Vials/Year

Product Description

Nefopam Hydrochloride Injection
Product name: Nefopam Hydrochloride Injection
Main ingredients and chemical name: every 1ml contain: NEFOPAM HYDROCHLORIDE  0.02mg
Character The product is a colorless clear liquid.
Pharmacology and toxicityPharmacological action
Nefopam hydrochloride is a non-narcotic central analgesic whose structure is different from other known analgesics. In vitro, nefopam hydrochloride inhibited the reuptake of catecholamine and serotonin in rat synaptosomes. In animal studies, nefopam showed analgesic properties. Nefopam hydrochloride also has antihyperalgesia effect, but its mechanism has not been fully confirmed. In clinical trials, nefopam hydrochloride has an effect on postoperative chills. Nefopam hydrochloride has no anti-inflammatory and antipyretic activity. Nefopam hydrochloride did not cause respiratory depression or reduced intestinal transport. Nefopam hydrochloride has anticholinergic activity. Nefopam hydrochloride can cause a moderate but transient increase in heart rate and blood pressure.

Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948, now it is a large-sized foreign invested enterprise and comprehensive medicine manufacturer in China, the capital is USD58 million, and with more than 3000 employees. The company can manufacture 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc with GMP approval by SFDA of China. For the key product of large volume I.V solution, the yearly output has reached more than 1200 million bottles including 40 million bottles packing with the soft plastic bottles in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China.  

The products have been sold to some countries and regions in South America, Africa, and Asia.Small Volume Nefopam Hydrochloride InjectionSmall Volume Nefopam Hydrochloride InjectionSmall Volume Nefopam Hydrochloride InjectionSmall Volume Nefopam Hydrochloride InjectionSmall Volume Nefopam Hydrochloride Injection

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier